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Abstract
Background and Purpose—Little is known on long-term follow-up after thrombolysis in ischemic stroke
patients because the majority of studies evaluated outcome at 3 to 12 months. We aimed to assess 5-
year outcome after intravenous thrombolysis (IVT).
Methods—Cohort study based on the prospective registry of all consecutive ischemic stroke patients
submitted to IVT in our Stroke Unit. Five-year outcome, including living settings, functional outcome,
stroke recurrence, and mortality, was ascertained by telephonic interviews and additional review of
clinical records. Multivariate analyses were performed to identify predictors of outcome and mortality.
Excellent outcome was defined as modified Rankin scale 0 to 1.
Results—Five-year outcome was available for 155/164 patients submitted to IVT. At 5 years, 32.9% of
patients had an excellent outcome (95% confidence interval (CI) =25.5–43.3) and mortality was 43.9%
(95%CI=36.1–51.7). Increasing age (odds ratio =0.93, 95% CI =0.90–0.97) and increasing National
Institute of Health Stroke Scale (NIHSS) 24 h after thrombolysis (odds ratio =0.81, 95% CI =0.74–0.90)
were independently associated with a lower likelihood of an excellent 5-year outcome. Age (hazards ratio
=1.07, 95% CI =1.03–1.11) and excellent functional outcome 3 months after thrombolysis (hazards ratio
=0.28, 95%CI=0.12–0.66) were independently associated with mortality during follow-up.
Conclusions—One third of ischemic stroke patients have excellent 5-year outcome after IVT. Younger
age, lower NIHSS 24 h after IVT, and excellent 3-month functional outcome are independent predictors
of excellent 5-year outcome.
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Introduction
Thrombolytic therapy with intravenous alteplase (IVT) is an effective treatment in acute ischemic stroke
when administered ≤4.5 h.  However, most studies addressing outcome have a relatively short follow-up
period. Data on long-term outcome is scarce.  We aimed to assess 5-year outcome after IVT and to
identify predictors of excellent outcome and long-term mortality.
Methods
Patients and Variables
Cohort study based on the prospective registry of consecutive ischemic stroke patients submitted to IVT
in our hospital between February 2007 and February 2010. Clinical data were collected from the
registry. Five-year outcome was ascertained by standardized telephone interviews to patients or carers
when the patient was unable to provide information. Information on living settings, functional outcome
(modified Rankin scale, mRS), stroke recurrence, and mortality was collected. Clinical records in our
hospital and regional hospitals were reviewed to collect and confirm follow-up. Outcome was defined as
excellent (mRS 0–1) or unfavorable (mRS 2–6). The study complies with the Helsinki Declaration and the
local ethics committee requirements for clinical research.
Statistical Methods
Groups of excellent and unfavorable outcome were compared using χ , independent-samples t-student
and Mann–Whitney U tests as appropriate. Binary logistic regression using 5-year outcome (dependent
variable) and variables with P<0.01 in univariate analysis (covariates), and survival analysis with Cox
proportional hazards regression model using out-of-hospital mortality as end-point were calculated. A
sensitivity analysis using the multiple imputations method was performed to account for missing values.
IBM SPSS Statistics (version 20) was used.
Results
Five-year outcome was available for 155/164 patients (94.5%) consecutively submitted to IVT. Baseline
characteristics are described in Table 1. Patients with excellent outcome had a lower median age
(P<0.001), lower median admission National Institute of Health Stroke Scale (NIHSS; P<0.001), less
frequently had Total Anterior Circulation Infarct syndrome (P<0.001), had lower NIHSS score 24 h after
thrombolysis (P<0.001), and more frequently presented excellent outcome 3 months after thrombolysis
(P<0.001). Mortality at 5 years was 43.9% (n=68), and survival curve is shown in Figure . In-hospital
mortality during index stroke admission was 9.0% (n=14). Causes of out-of-hospital mortality were acute
infectious disease (n=16), organ-specific terminal failure (n=7), stroke recurrence (n=6), neoplastic
disease (n=6), sudden death (n=5), and unknown in 14 patients. At 3 months, 39.4% of patients had
mRS 0 to 1, and mortality after 3 months was lower in this group (P<0.001; Figure I in the online-only
Data Supplement). Seventy percent of the patients who were alive at 5 years had NIHSS 24 h after
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were in a nursing home. Twelve of the 87 patients (13.8%) were professionally active at 5 years. Stroke
recurred in 12 patients. Increasing age (odds ratio =0.93, 95% confidence interval =0.90–0.97) and
increasing NIHSS 24 h after thrombolysis (odds ratio =0.81, 95% confidence interval =0.74–0.90) were
independently associated with lower likelihood of excellent 5-year outcome (Table 2). Age (hazards
ratio=1.07, 95% confidence interval =1.03–1.11) and excellent outcome at 3 months (hazards ratio
=0.28, 95% confidence interval =0.12–0.66) were independently associated with mortality during follow-
up (Table 2). Sensitivity analysis did not alter the results significantly (Table I in the online-only Data
Supplement).
Table 1.
Characteristics of Patients According to Five-Year Outcome
Table 2.
Binomial Logistic Regression and Multivariate Survival Analyses
Download figure








Five years after IVT, 1/3 patients had excellent outcome (mRS 0–1) and almost 1/2 had died. Younger
age and lower NIHSS 24 h after IVT were independent predictors of excellent 5-year outcome. Gensicke
et al  found that higher admission stroke severity was a predictor of unfavorable outcome, but our
analysis showed that when adjusted for NIHSS 24 h after IVT, admission stroke severity is no longer a
predictor of long-term functional outcome. This suggests that neurological improvement after IVT is a
robust predictor of an excellent 5-year outcome, irrespective of initial clinical severity. Studies with long-
term follow-up (1–4 years) reported a cumulative mortality of 15% to 53% after IVT.  Only 3 studies
had follow-up >12 months, and ours is the first to include 5-year follow-up. Prethrombolytic era 5-year
mortality in stroke patients admitted to Stroke Units ranged from 45 to 59.1%,  and despite lower 5-
year mortality in our cohort, direct comparison has limited validity. Annual mortality rate was higher
during the first year, decreasing gradually afterward. Age and 3-month outcome were the only
independent predictors of 5-year mortality. Although clinical severity 24 h after thrombolysis did not have
an impact on long-term mortality, this may be related to a floor effect of the NIHSS. However, excellent 3-
month functional outcome was associated with 3.5-fold increase in the likelihood of being alive at 5
years. Our study is in line with observational community-based studies, which showed that ischemic
stroke disability predicts 5-year and 7-year survival  and confirms that better short-term functional
outcome after thrombolysis is associated with higher likelihood of being alive at 5 years.
Conclusions
Approximately 1/3 patients had an excellent 5-year outcome after IVT. Clinical improvement 24 h after
IVT is independently associated with excellent long-term outcome, and a better functional outcome at 3
months is associated with long-term survival.
Acknowledgments
We acknowledge Helena Vilaça MD, Marta Marques MD, and all members of the Neurology Department




The online-only Data Supplement is available with this article at
http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.115.009842/-/DC1.
Received May 18, 2015.
Revision received June 2, 2015.





14/10/2016 Five-Year Outcome in Stroke Patients Submitted to Thrombolysis |  Stroke
http://stroke.ahajournals.org/content/46/8/2312.full.print 5/7
© 2015 American Heart Association, Inc.
References
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al; ECASS Investigators. Thrombolysis with 3 to 4.5 hours
after acute ischemic stroke. N Engl Med . 2008; 359: 1317–1329.
1.
Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, et al. Effects of tissue plasminogen
activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke
Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med . 1999;340:1781–1787. doi:
10.1056/NEJM199906103402302.
2.
Schmülling S, Grond M, Rudolf J, Heiss WD. One-year follow-Up in acute stroke patients treated with rtPA in
clinical routine. Stroke . 2000;31:1552–1554.
3.
Gensicke H, Seiffge DJ, Polasek AE, Peters N, Bonati LH, Lyrer PA, et al. Long-term outcome in stroke patients
treated with IV thrombolysis. Neurology . 2013;80:919–925. doi: 10.1212/WNL.0b013e3182840c35.
4.
Schmitz ML, Simonsen CZ, Hundborg H, Christensen H, Ellemann K, Geisler K, et al. Acute ischemic stroke and
long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study. Stroke .
2014;45:3070–3072. doi: 10.1161/STROKEAHA.114.006570.
5.
Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, et al.; IST-3 Collaborative Group. Effect of
alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial). Stroke .
2014;45:3612–3617. doi: 10.1161/STROKEAHA.114.006890.
6.
Indredavik B, Slørdahl SA, Bakke F, Rokseth R, Håheim LL. Stroke unit treatment. Long-term effects. Stroke .
1997;28:1861–1866.
7.
Husbands SL, Lincoln NB, Drummond AER, Gladman J, Trescoli C. Five-year results of a randomized controlled
trial of a stroke rehabilitation unit. Clin Rehabil . 1999; 13:530–531.
8.
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever
stroke and related prognostic factors in the Perth Community Stroke Study. Stroke . 2000;31:2080–2086.
9.
Magalhães R, Abreu P, Correia M, Whiteley W, Silva MC, Sandercock P. Functional status three months after the
first ischemic stroke is associated with long-term outcome: data from a community-based cohort. Cerebrovasc






































Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do.
The need for our work is beyond question. Find Out More
Careers 
SHOP 
Latest Heart and Stroke News 
AHA/ASA Media Newsroom 
OUR SITES
American Heart Association 
American Stroke Association 









You're the Cure 
ONLINE COMMUNITIES
AFib Support 
Empowered to Serve 
Garden Community 
Patient Support Network 
Professional Online Network 
Follow Us:
      
Privacy Policy  Copyright  Ethics Policy  Conflict of Interest Policy  Linking Policy  Diversity  Careers
©2016 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart
Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.
